ClinicalTrials.Veeva

Find clinical trials for Colon Cancer in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Neoplasm Metastasis
Adenocarcinoma
Lung Cancer
Pancreatic Cancer

Colon Cancer trials near Boston, MA, USA:

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

This study seeks to learn more about the vitamin D receptor and its relationship to colon cancer. The Vitamin D receptor is found i ...

Enrolling
Stage, Colon Cancer
Stage IV Colon Cancer With Resectable Liver Metastases
Drug: Vitamin D3
Drug: Placebo

Early Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States

The purpose of this study is to examine if Nivolumab by itself, or Nivolumab in combination with other anti-cancer drugs, will result in mea ...

Active, not recruiting
Microsatellite Unstable Colorectal Cancer
Microsatellite Stable Colorectal Cancer
Drug: Ipilimumab
Drug: Daratumumab

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Boston, Massachusetts, United States and 32 other locations

This is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitr...

Active, not recruiting
Glioma
Chondrosarcoma
Drug: Cisplatin
Drug: LY3410738

Phase 1

Lilly
Lilly

Boston, Massachusetts, United States and 32 other locations

to participants with advanced solid tumors, including rearranged during transfection (RET)-fusion-positive solid tumors, medullary thyroid cancer...

Enrolling
Colon Cancer
Medullary Thyroid Cancer
Drug: LOXO-292

Phase 1, Phase 2

Loxo Oncology
Loxo Oncology

Boston, Massachusetts, United States and 83 other locations

the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 6 month
Drug: mFOLFOX6 3-6 month

Phase 2, Phase 3

NRG Oncology

Boston, Massachusetts, United States and 827 other locations

This study is to evaluate the safety and tolerability of RMC-9805 in adults with KRAS G12D-mutant solid tumors.

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-9805

Phase 1

Revolution Medicines
Revolution Medicines

Boston, Massachusetts, United States and 6 other locations

Evaluate the safety and tolerability of RMC-6236 in adults with specific RAS mutant advanced solid tumors.

Enrolling
Non-small Cell Lung Cancer (NSCLC)
Colorectal Cancer (CRC)
Drug: RMC-6236

Phase 1

Revolution Medicines
Revolution Medicines

Boston, Massachusetts, United States and 14 other locations

Phase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary antitumor activity of CO...

Enrolling
Advanced Cancer
Colon Cancer
Drug: Cohort expansion: COM902 (RDFE) monotherapy.
Drug: Cohort expansion: COM902 in combination with COM701 (both at the RDFE).

Phase 1

Compugen

Boston, Massachusetts, United States and 8 other locations

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 in combination with TNO155 in pat...

Active, not recruiting
Metastatic Cancer
Advanced Cancer
Drug: MRTX849
Drug: TNO155

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Boston, Massachusetts, United States and 11 other locations

A Phase 1/2 Open-label, Multi-center Study of the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and in Combination with Chemothe...

Enrolling
Metastatic Cancer
Head and Neck Cancer
Drug: LYT-200
Drug: Gemcitabine/nab-paclitaxel

Phase 1, Phase 2

PureTech Health

Boston, Massachusetts, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems